Ayushakti Ayurved: Redefining Care With Comprehensive Ancient Ayurvedic Solution

Krushna Pankaj Naram, CEO, Smita Pankaj Naram, Co-Founder

Krushna Pankaj Naram, CEO

Smita Pankaj Naram, Co-Founder

The ayurvedic industry is experiencing a transforma­tive surge, powered by rising global interest in holistic health, wellness tourism, and natural alternatives to conventional medicine. Given the growing tendency of con­sumers to look for sustainable and preventive options for chronic health conditions, Ayurveda has come back in terms of relevance for its integrative and nature-based approach. This old Indian medicinal practice is gaining significant trac­tion in the contemporary wellness ecosystems as it works with global paradigms to bring mindful living, clean-label of­ferings, and individualized health solutions to the forefront. Supported by increasing scientific studies and partnership with institutions, Ayurveda is emerging as a mainstream phe­nomenon in global healthcare.

At the front line of this evolution is Ayushakti Ayurved, a trailblazing ayurvedic organization with almost four decades of unparalleled experience. Built on the foundations of the genuine ayurvedic treatment, the company has surged to the forefront of the global practices of result based natural solutions. With operations in over 108 countries coupled with more than 1.5 million patients having been served, the company combines time-tested traditional knowledge with a structured, scientific approach to health and wellness. Furthermore, the organization differentiates itself in addressing complex modern-day health disorders through personalized therapies grounded in the classical Ayurvedic principles, while meeting modern-day health expectations of different people with varied cultures and locations.

Beyond Generic Wellness

Ayushakti Ayurved has meticulously addressed a major market gap by providing systematic-results oriented treatments for chronic-ailments like asthma, arthritis, diabetes, depression, and skin disorders. Unlike most of the players in the ayurvedic space which provides generic solutions around wellness, Ayushakti Ayurved's strength lies in being structured in its diagnostic and therapeutic approach.

At the heart of it is the old science of pulse diagnosis (Nadi Pariksha), with its ability to identify in-depth imbalances and adjust treatments accordingly. “Our stand-alone healing system is based on customized herbal formulations, personalized detoxification therapies and lifestyle recommendations which offer long-term relief and prevention, rather than treating symptoms temporarily”, explains Smita Pankaj Naram, Co-Founder, Ayushakti Ayurved.

Furthermore, Clinical effectiveness remains the pillar of Ayushakti Ayurved's reputation and evolution. Over the years, the company has compiled thousands of documented case studies and practiced clinical evidence that have illustrated long-term effects of its herbal treatment. This evidence-based approach is additionally supported by its involvement in international research collaboration, as well as clinical trials. Additionally, with more than 50 research papers published in peer-reviewed international journals, the organization has immensely contributed to the validation of ayurveda’s role in chronic disease management. These scientific endeavors along with regular client testimonials and follow-up data present the credibility and quantifiable success of its treatment protocols.

Maintaining Global Standards Through Structured Excellence

In order to align consistency and high standards across its global clinic network, Ayushakti Ayurved works with strict mechanisms of quality control. The company works on standardized operating procedures in all touchpoints including initial consultations as well as post-treatment follow-ups. Its herbal medicines are produced in GMP-certified places that emphasize purity, potency, and safety by subjecting them to strict testing. In addition to this, centralized review, periodic audits, and having the input of senior.

Furthermore, ayurvedic practitioners in remote consultations ensure the maintenance of care integrity and authenticity regardless of geographic locations. This strong quality framework builds clients’ trust in the organization irrespective of whether they are looking for services in India or abroad.

Ayushakti Ayurved’s stand-alone healing system is based on customized herbal formulations, personalized detoxification therapies and lifestyle recommendations which offer long-term relief and prevention, rather than treating symptoms temporarily

Krushna Pankaj Naram, CEO, Smita Pankaj Naram, Co-Founder

Additionally, client-centricity continues to be one of the cornerstones in the constant evolution of the organization. The company regards users’ feedback and has created systems for the collection and analysis of client experience in different phases of the healing process. This directs the improvement in the treatment protocols, product innovation and service delivery. By keeping itself rooted in the outcomes of patients, Ayushakti Ayurved makes sure that its offerings are relevant, effective, and are meeting actual demands in the real world. “The sustained relationship that it develops with the clients does not only create loyal clients but also act as useful data sources for improving clinical practices and product formulations”, says Smita.

Innovating Ayurveda for Global Access

Innovation tends to make Ayushakti Ayurved's solutions more accessible and understandable to the contemporary global audience. The organization has leveraged technology by providing video consultations, streamlining detox programs and by incorporating digital equipment for pulse diagnosis. These innovations make Ayurveda accessible to everyone and guarantee the effectiveness of treatment and its personalization at the same time. The organization also conducts international training programs to educate and equip both clients and practitioners with authentic Ayurvedic knowledge.

Another distinguishing feature among Ayushakti Ayurved's therapeutic arsenals is its Panchakarma detox program designed around its proprietary 3R Healing System, namely Remove toxins, Restore body functions, and Renew cells. Tailored to individual needs, this personalized detox program addresses the root causes of health issues by balancing the body’s doshas, helping manage IBS, fatigue, hormonal issues, and more.

A Vision for Global Ayurvedic Empowerment

Going forward, Ayushakti Ayurved has laid a clear and ambitious five-year plan that reflects its commitment to extend the contribution of Ayurveda to the people around the world. The organization aims to achieve $70 million in global revenue and set up more than 100 clinics internationally. At the same time, the organization is focused on expanding its range of research-backed herbal formulations and driving growth through strategic partnerships and franchise models. By combining authenticity with scalability, the organization is steadily positioning Ayurveda as a trusted, household solution for chronic health challenges across the globe.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2026 India Pharma Outlook. All Rights Reserved.